Group One Trading, L.P. F Star Therapeutics, Inc. Transaction History

Group One Trading, L.P.

  • $2.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
BUY
$4.09 - $6.86 $715 - $1,200
175 New
175 $1,000
Q4 2021

Feb 11, 2022
SELL
$4.71 - $7.38 $942 - $1,476
-200 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$5.2 - $8.42 $1,040 - $1,684
200 New
200 $1,000

Others Institutions Holding FSTX

# of Institutions
3
Shares Held
44.7K
Call Options Held
0
Put Options Held
0
View Full List

About F-star Therapeutics, Inc.

FSTX Quotes by TradingView
  • Ticker FSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,584,700
  • Description
  • F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...
More about FSTX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email